All Stories

  1. Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas

    Article • Blood and Lymphatic Cancer Targets and Therapy, March 2016, Dove Medical Press

    alex almasan, Dr Mitchell R Smith, Dr Yazan Madanat